{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T03:20:56Z","timestamp":1793848856241,"version":"4.6.1"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T00:00:00Z","timestamp":1753401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T00:00:00Z","timestamp":1753401600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100008272","name":"Novartis Pharmaceuticals Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatol Ther (Heidelb)"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s13555-025-01496-x","type":"journal-article","created":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T16:20:39Z","timestamp":1753460439000},"page":"2715-2727","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Exploring the Experience of Black Americans Living with Hidradenitis Suppurativa in the United States Healthcare System: A Narrative Review"],"prefix":"10.1007","volume":"15","author":[{"given":"Nicole A.","family":"Negbenebor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8056-2403","authenticated-orcid":false,"given":"Julia M.","family":"Riley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,25]]},"reference":[{"key":"1496_CR1","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1001\/jama.2021.13304","volume":"326","author":"A Flanagin","year":"2021","unstructured":"Flanagin A, Frey T, Christiansen SL. Updated guidance on the reporting of race and ethnicity in medical and science journals. JAMA. 2021;326:621\u20137.","journal-title":"JAMA"},{"key":"1496_CR2","doi-asserted-by":"publisher","first-page":"906","DOI":"10.5811\/WESTJEM.58408","volume":"24","author":"WL Macias-Konstantopoulos","year":"2023","unstructured":"Macias-Konstantopoulos WL, Collins KA, Diaz R, et al. Race, healthcare, and health disparities: a critical review and recommendations for advancing health equity. West J Emerg Med. 2023;24:906\u201318.","journal-title":"West J Emerg Med"},{"key":"1496_CR3","first-page":"92","volume":"27","author":"AS Byrd","year":"2023","unstructured":"Byrd AS, Rosenberg AZ, Shipman WD, et al. Hidradenitis suppurativa in Black and White patients\u2014a clinical study. Eur Rev Med Pharmacol Sci. 2023;27:92\u20138.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"1496_CR4","doi-asserted-by":"publisher","first-page":"E25","DOI":"10.12788\/cutis.0811","volume":"111","author":"SA Weir","year":"2023","unstructured":"Weir SA, MacLennan P, Kole LCS. Racial disparities in hidradenitis suppurativa-related pain: a cross-sectional analysis. Cutis. 2023;111:E25\u201330.","journal-title":"Cutis"},{"key":"1496_CR5","doi-asserted-by":"publisher","first-page":"545","DOI":"10.2147\/CCID.S402453","volume":"16","author":"HM Alotaibi","year":"2023","unstructured":"Alotaibi HM. Incidence, risk factors, and prognosis of hidradenitis suppurativa across the globe: insights from the literature. Clin Cosmet Investig Dermatol. 2023;16:545\u201352.","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"1496_CR6","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1159\/000486741","volume":"233","author":"DE Lee","year":"2017","unstructured":"Lee DE, Clark AK, Shi VY. Hidradenitis suppurativa: disease burden and etiology in skin of color. Dermatology. 2017;233:456\u201361.","journal-title":"Dermatology"},{"key":"1496_CR7","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1159\/000477412","volume":"3","author":"MA Castrillon Velasquez","year":"2017","unstructured":"Castrillon Velasquez MA, Kim M, Tan MH, Tran K, Murrell DF. An atypical localized form of hidradenitis suppurativa of the jawline and neck mimicking severe cystic acne on presentation. Skin Appendage Disord. 2017;3:215\u20138.","journal-title":"Skin Appendage Disord"},{"key":"1496_CR8","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.jaad.2009.02.013","volume":"61","author":"F Canoui-Poitrine","year":"2009","unstructured":"Canoui-Poitrine F, Revuz JE, Wolkenstein P, et al. Clinical characteristics of a series of 302 French patients with hidradenitis suppurativa, with an analysis of factors associated with disease severity. J Am Acad Dermatol. 2009;61:51\u20137.","journal-title":"J Am Acad Dermatol"},{"key":"1496_CR9","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.jaad.2019.02.068","volume":"81","author":"A Alikhan","year":"2019","unstructured":"Alikhan A, Sayed C, Alavi A, et al. North American clinical management guidelines for hidradenitis suppurativa: a publication from the United States and Canadian Hidradenitis Suppurativa Foundations: Part II: Topical, intralesional, and systemic medical management. J Am Acad Dermatol. 2019;81:91\u2013101.","journal-title":"J Am Acad Dermatol"},{"key":"1496_CR10","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1159\/000514582","volume":"237","author":"N Almuhanna","year":"2021","unstructured":"Almuhanna N, Finstad A, Alhusayen R. Association between hidradenitis suppurativa and inflammatory arthritis: a systematic review and meta-analysis. Dermatology. 2021;237:740\u20137.","journal-title":"Dermatology"},{"key":"1496_CR11","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1001\/jamadermatol.2019.4590","volume":"156","author":"MC Schneeweiss","year":"2020","unstructured":"Schneeweiss MC, Kim SC, Schneeweiss S, Rosmarin D, Merola JF. Risk of inflammatory arthritis after a new diagnosis of hidradenitis suppurativa. JAMA Dermatol. 2020;156:342\u20135.","journal-title":"JAMA Dermatol"},{"key":"1496_CR12","doi-asserted-by":"publisher","first-page":"9","DOI":"10.4161\/derm.2.1.12490","volume":"2","author":"S Fimmel","year":"2010","unstructured":"Fimmel S, Zouboulis CC. Comorbidities of hidradenitis suppurativa (acne inversa). Dermatoendocrinol. 2010;2:9\u201316.","journal-title":"Dermatoendocrinol"},{"key":"1496_CR13","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1111\/bjd.13777","volume":"173","author":"G Shalom","year":"2015","unstructured":"Shalom G, Freud T, Harman-Boehm I, Polishchuk I, Cohen AD. Hidradenitis suppurativa and metabolic syndrome: a comparative cross-sectional study of 3207 patients. Br J Dermatol. 2015;173:464\u201370.","journal-title":"Br J Dermatol"},{"key":"1496_CR14","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.2147\/CCID.S301794","volume":"16","author":"CL Snyder","year":"2023","unstructured":"Snyder CL, Chen SX, Porter ML. Obstacles to early diagnosis and treatment of hidradenitis suppurativa: current perspectives on improving clinical management. Clin Cosmet Investig Dermatol. 2023;16:1833\u201341.","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"1496_CR15","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.jaad.2019.02.067","volume":"81","author":"A Alikhan","year":"2019","unstructured":"Alikhan A, Sayed C, Alavi A, et al. North American clinical management guidelines for hidradenitis suppurativa: a publication from the United States and Canadian Hidradenitis Suppurativa Foundations: Part I: diagnosis, evaluation, and the use of complementary and procedural management. J Am Acad Dermatol. 2019;81:76\u201390.","journal-title":"J Am Acad Dermatol"},{"key":"1496_CR16","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1370\/afm.2632","volume":"19","author":"M Bazargan","year":"2021","unstructured":"Bazargan M, Cobb S, Assari S. Discrimination and medical mistrust in a racially and ethnically diverse sample of California adults. Ann Fam Med. 2021;19:4\u201315.","journal-title":"Ann Fam Med"},{"key":"1496_CR17","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1016\/j.amjmed.2022.04.010","volume":"135","author":"C Caraballo","year":"2022","unstructured":"Caraballo C, Herrin J, Mahajan S, et al. Temporal trends in racial and ethnic disparities in multimorbidity prevalence in the United States, 1999\u20132018. Am J Med. 2022;135:1083\u201392.e14.","journal-title":"Am J Med"},{"key":"1496_CR18","unstructured":"Centers for Disease Control and Prevention. Fast facts: HIV in the US by race and ethnicity. Published May 21, 2024. https:\/\/www.cdc.gov\/hiv\/data-research\/facts-stats\/race-ethnicity.html. Accessed 18 Feb 2025."},{"key":"1496_CR19","unstructured":"Centers for Disease Control and Prevention. National diabetes statistics report. Published May 15, 2024. https:\/\/www.cdc.gov\/diabetes\/php\/data-research\/index.html. Accessed 18 Feb 2025."},{"key":"1496_CR20","unstructured":"Hales CM, Carroll MD, Fryar CD, Ogden CL; National Center for Health Statistics. Prevalence of obesity and severe obesity among adults: United States, 2017\u20132018. NCHS Data Brief. Published February 2020. https:\/\/www.cdc.gov\/nchs\/products\/databriefs\/db360.htm. Accessed 20 Mar 2025."},{"key":"1496_CR21","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1001\/jamadermatol.2021.2999","volume":"157","author":"E Edigin","year":"2021","unstructured":"Edigin E, Kaul S, Eseaton PO, Albrecht J. Racial and ethnic distribution of patients hospitalized with hidradenitis suppurativa, 2008\u20132018. JAMA Dermatol. 2021;157:1125\u20137.","journal-title":"JAMA Dermatol"},{"key":"1496_CR22","doi-asserted-by":"crossref","unstructured":"Curtin SC; National Center for Health Statistics. Stroke death rates among adults ages 45\u201364 by region and race and Hispanic origin: United States, 2002\u20132022. NCHS Data Brief. Published August 2024. https:\/\/www.cdc.gov\/nchs\/products\/databriefs\/db505.htm. Accessed 20 Mar 2025.","DOI":"10.15620\/cdc\/158326"},{"key":"1496_CR23","unstructured":"National Center for Health Statistics. Health, United States spotlight: racial and ethnic disparities in heart disease. Published April 2019. https:\/\/www.cdc.gov\/nchs\/hus\/spotlight\/HeartDiseaseSpotlight_2019_0404.pdf. Accessed 24 Feb 2025."},{"key":"1496_CR24","doi-asserted-by":"crossref","unstructured":"Ely DM, Driscoll AK; National Vital Statistics Reports. Infant mortality in the United States, 2022: data from the period linked birth\/infant death file. Revised August 22, 2024. https:\/\/www.cdc.gov\/nchs\/data\/nvsr\/nvsr73\/nvsr73-05.pdf. Accessed 20 Mar 2025.","DOI":"10.15620\/cdc\/157006"},{"key":"1496_CR25","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S0140-6736(22)00876-5","volume":"400","author":"GBD US Health Disparities Collaborators","year":"2022","unstructured":"GBD US Health Disparities Collaborators. Life expectancy by county, race, and ethnicity in the USA, 2000\u201319: a systematic analysis of health disparities. Lancet. 2022;400:25\u201338.","journal-title":"Lancet"},{"key":"1496_CR26","first-page":"27","volume":"16","author":"V Kodumudi","year":"2023","unstructured":"Kodumudi V, Gronbeck C, Feng H. Practice characteristics of self-identified Black dermatologists in the United States. J Clin Aesthet Dermatol. 2023;16:27\u20139.","journal-title":"J Clin Aesthet Dermatol"},{"key":"1496_CR27","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.socscimed.2018.02.023","volume":"202","author":"P Louie","year":"2018","unstructured":"Louie P, Wilkes R. Representations of race and skin tone in medical textbook imagery. Soc Sci Med. 2018;202:38\u201342.","journal-title":"Soc Sci Med"},{"key":"1496_CR28","first-page":"1215","volume":"315","author":"S Narla","year":"2023","unstructured":"Narla S, Heath CR, Alexis A, Silverberg JI. Racial disparities in dermatology. Arch Dermatol Res. 2023;315:1215\u201323.","journal-title":"Arch Dermatol Res"},{"key":"1496_CR29","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.36849\/JDD.7713","volume":"22","author":"MM Cartwright","year":"2023","unstructured":"Cartwright MM, Kamen T, Desai SR. The psychosocial burden of skin disease and dermatology care insights among skin of color consumers. J Drugs Dermatol. 2023;22:1027\u201333.","journal-title":"J Drugs Dermatol"},{"key":"1496_CR30","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1007\/s10067-014-2763-3","volume":"34","author":"GS Kerr","year":"2015","unstructured":"Kerr GS, Qaiyumi S, Richards J, et al. Psoriasis and psoriatic arthritis in African-American patients\u2013the need to measure disease burden. Clin Rheumatol. 2015;34:1753\u20139.","journal-title":"Clin Rheumatol"},{"key":"1496_CR31","doi-asserted-by":"publisher","first-page":"E79","DOI":"10.5888\/pcd16.180640","volume":"16","author":"MB Culp","year":"2019","unstructured":"Culp MB, Lunsford NB. Melanoma among non-Hispanic Black Americans. Prev Chronic Dis. 2019;16:E79.","journal-title":"Prev Chronic Dis"},{"key":"1496_CR32","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1001\/jamadermatol.2022.3601","volume":"158","author":"PB Allen","year":"2022","unstructured":"Allen PB, Goyal S, Niyogusaba T, et al. Clinical presentation and outcome differences between Black patients and patients of other races and ethnicities with mycosis fungoides and S\u00e9zary syndrome. JAMA Dermatol. 2022;158:1293\u20139.","journal-title":"JAMA Dermatol"},{"key":"1496_CR33","volume":"14","author":"A Patel","year":"2022","unstructured":"Patel A, Patel A, Solanki D, et al. Hidradenitis suppurativa in the United States: insights from the National Inpatient Sample (2008\u20132017) on contemporary trends in demographics, hospitalization rates, chronic comorbid conditions, and mortality. Cureus. 2022;14:e24755.","journal-title":"Cureus"},{"key":"1496_CR34","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1001\/jamadermatol.2017.0201","volume":"153","author":"A Garg","year":"2017","unstructured":"Garg A, Kirby JS, Lavian J, Lin G, Strunk A. Sex- and age-adjusted population analysis of prevalence estimates for hidradenitis suppurativa in the United States. JAMA Dermatol. 2017;153:760\u20134.","journal-title":"JAMA Dermatol"},{"key":"1496_CR35","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/jdv.16677","volume":"35","author":"TV Nguyen","year":"2021","unstructured":"Nguyen TV, Damiani G, Orenstein LAV, Hamzavi I, Jemec GB. Hidradenitis suppurativa: an update on epidemiology, phenotypes, diagnosis, pathogenesis, comorbidities and quality of life. J Eur Acad Dermatol Venereol. 2021;35:50\u201361.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1496_CR36","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.amjmed.2022.09.025","volume":"136","author":"A Garg","year":"2023","unstructured":"Garg A, Naik HB, Kirby JS. A practical guide for primary care providers on timely diagnosis and comprehensive care strategies for hidradenitis suppurativa. Am J Med. 2023;136:42\u201353.","journal-title":"Am J Med"},{"key":"1496_CR37","volume":"15","author":"MR Anthony","year":"2023","unstructured":"Anthony MR, Abdi P, Farkouh C, Maibach HI. Unmasking racial disparity in the diagnosis and treatment of hidradenitis suppurativa. Cureus. 2023;15:e41190.","journal-title":"Cureus"},{"key":"1496_CR38","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1177\/1203475420972348","volume":"25","author":"M Sachdeva","year":"2021","unstructured":"Sachdeva M, Shah M, Alavi A. Race-specific prevalence of hidradenitis suppurativa. J Cutan Med Surg. 2021;25:177\u201387.","journal-title":"J Cutan Med Surg"},{"key":"1496_CR39","first-page":"613","volume":"114","author":"L Serrano","year":"2022","unstructured":"Serrano L, Ulschmid C, Szabo A, Roth G, Sokumbi O. Racial disparities of delay in diagnosis and dermatologic care for hidradenitis suppurativa. J Natl Med Assoc. 2022;114:613\u20136.","journal-title":"J Natl Med Assoc"},{"key":"1496_CR40","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1159\/000508787","volume":"236","author":"G Kokolakis","year":"2020","unstructured":"Kokolakis G, Wolk K, Schneider-Burrus S, et al. Delayed diagnosis of hidradenitis suppurativa and its effect on patients and healthcare system. Dermatology. 2020;236:421\u201330.","journal-title":"Dermatology"},{"key":"1496_CR41","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.jaad.2021.02.066","volume":"86","author":"A Jfri","year":"2022","unstructured":"Jfri A, Litvinov IV, Netchiporouk E, O\u2019Brien E. Clinical and psychosocial factors affecting work productivity among patients with hidradenitis suppurativa: a cluster analytical investigation. J Am Acad Dermatol. 2022;86:675\u20137.","journal-title":"J Am Acad Dermatol"},{"key":"1496_CR42","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.jdin.2021.01.007","volume":"3","author":"JM Kilgour","year":"2021","unstructured":"Kilgour JM, Li S, Sarin KY. Hidradenitis suppurativa in patients of color is associated with increased disease severity and healthcare utilization: a retrospective analysis of 2 US cohorts. JAAD Int. 2021;3:42\u201352.","journal-title":"JAAD Int"},{"key":"1496_CR43","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1111\/ijd.16428","volume":"62","author":"C Ulschmid","year":"2023","unstructured":"Ulschmid C, Serrano L, Wu R, Roth GM, Sokumbi O. African American race is a risk factor for severe hidradenitis suppurativa. Int J Dermatol. 2023;62:657\u201363.","journal-title":"Int J Dermatol"},{"key":"1496_CR44","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1001\/jamadermatol.2019.0164","volume":"155","author":"S Reddy","year":"2019","unstructured":"Reddy S, Strunk A, Garg A. Comparative overall comorbidity burden among patients with hidradenitis suppurativa. JAMA Dermatol. 2019;155:797\u2013802.","journal-title":"JAMA Dermatol"},{"key":"1496_CR45","first-page":"270","volume":"21","author":"I Robinson","year":"2022","unstructured":"Robinson I, Lee L, Cotton C. The impact of racial differences on treatment strategies in hidradenitis suppurativa: a retrospective review. J Drugs Dermatol. 2022;21:270\u20135.","journal-title":"J Drugs Dermatol"},{"key":"1496_CR46","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1001\/jamadermatol.2022.4610","volume":"158","author":"CX Wang","year":"2022","unstructured":"Wang CX, Buss JL, Keller M, Anadkat MJ. Factors associated with dermatologic follow-up vs emergency department return in patients with hidradenitis suppurativa after an initial emergency department visit. JAMA Dermatol. 2022;158:1378\u201386.","journal-title":"JAMA Dermatol"},{"key":"1496_CR47","doi-asserted-by":"publisher","first-page":"692","DOI":"10.36849\/JDD.6803","volume":"22","author":"I Moseley","year":"2023","unstructured":"Moseley I, Ragi SD, Handler MZ. Racial disparities in the treatment of hidradenitis suppurativa: an analysis of data from the National Ambulatory Medical Care survey. J Drugs Dermatol. 2023;22:692\u20133.","journal-title":"J Drugs Dermatol"},{"key":"1496_CR48","doi-asserted-by":"publisher","first-page":"2353","DOI":"10.1111\/j.1475-6773.2012.01417.x","volume":"47","author":"DJ Gaskin","year":"2012","unstructured":"Gaskin DJ, Dinwiddie GY, Chan KS, McCleary RR. Residential segregation and the availability of primary care physicians. Health Serv Res. 2012;47:2353\u201376.","journal-title":"Health Serv Res"},{"key":"1496_CR49","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.0138","volume":"2","author":"EL Tung","year":"2019","unstructured":"Tung EL, Hampton DA, Kolak M, Rogers SO, Yang JP, Peek ME. Race\/ethnicity and geographic access to urban trauma care. JAMA Netw Open. 2019;2: e190138.","journal-title":"JAMA Netw Open"},{"key":"1496_CR50","unstructured":"Keisler-Starkey K, Bunch LN. United States Census Bureau.\u00a0Health insurance coverage in the United States: 2021. Published September 13, 2022. https:\/\/www.census.gov\/library\/publications\/2022\/demo\/p60-278.html. Accessed 20 Mar 2025."},{"key":"1496_CR51","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1159\/000528253","volume":"9","author":"T Shih","year":"2023","unstructured":"Shih T, De DR, Rick J, Shi VY, Hsiao JL. Low rates of psychosocial screening and lifestyle counseling in hidradenitis suppurativa patients in the USA. Skin Appendage Disord. 2023;9:94\u20138.","journal-title":"Skin Appendage Disord"},{"key":"1496_CR52","doi-asserted-by":"publisher","first-page":"553","DOI":"10.2340\/00015555-1800","volume":"94","author":"CB Kromann","year":"2014","unstructured":"Kromann CB, Ibler KS, Kristiansen VB, Jemec GB. The influence of body weight on the prevalence and severity of hidradenitis suppurativa. Acta Derm Venereol. 2014;94:553\u20137.","journal-title":"Acta Derm Venereol"},{"key":"1496_CR53","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1007\/s00403-022-02510-4","volume":"315","author":"KG Elhage","year":"2023","unstructured":"Elhage KG, Davis MS, Hakimi M, et al. Ethnoracial representation in hidradenitis suppurativa clinical trials. Arch Dermatol Res. 2023;315:1793\u20136.","journal-title":"Arch Dermatol Res"},{"key":"1496_CR54","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1159\/000504911","volume":"237","author":"KN Price","year":"2021","unstructured":"Price KN, Hsiao JL, Shi VY. Race and ethnicity gaps in global hidradenitis suppurativa clinical trials. Dermatology. 2021;237:97\u2013102.","journal-title":"Dermatology"},{"key":"1496_CR55","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1159\/000516467","volume":"238","author":"CAV Okeke","year":"2022","unstructured":"Okeke CAV, Perry JD, Simmonds FC, et al. Clinical trials and skin of color: the example of hidradenitis suppurativa. Dermatology. 2022;238:180\u20134.","journal-title":"Dermatology"},{"key":"1496_CR56","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.jaad.2022.03.052","volume":"89","author":"D Omar","year":"2023","unstructured":"Omar D, Syder N, Brown-Korsah JB, McKenzie S, Elbuluk N, Taylor S. Racial and ethnic disparities in clinical research and the dermatology workforce: Part 2. J Am Acad Dermatol. 2023;89:895\u2013902.","journal-title":"J Am Acad Dermatol"},{"key":"1496_CR57","first-page":"e138","volume":"4","author":"B Muvuka","year":"2020","unstructured":"Muvuka B, Combs RM, Ayangeakaa SD, Ali NM, Wendel ML, Jackson T. Health literacy in African-American communities: barriers and strategies. Health Lit Res Pract. 2020;4:e138\u201343.","journal-title":"Health Lit Res Pract"},{"key":"1496_CR58","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1186\/s12889-022-13122-y","volume":"22","author":"S Hamed","year":"2022","unstructured":"Hamed S, Bradby H, Ahlberg BM, Thapar-Bj\u00f6rkert S. Racism in healthcare: a scoping review. BMC Public Health. 2022;22:988.","journal-title":"BMC Public Health"},{"key":"1496_CR59","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1001\/jamadermatol.2023.5425","volume":"160","author":"N Salame","year":"2024","unstructured":"Salame N, Sow YN, Siira MR, et al. Factors affecting treatment selection among patients with hidradenitis suppurativa. JAMA Dermatol. 2024;160:179\u201386.","journal-title":"JAMA Dermatol"},{"key":"1496_CR60","doi-asserted-by":"publisher","first-page":"16729","DOI":"10.1016\/j.jid.2018.12.032","volume":"139","author":"J Takeshita","year":"2019","unstructured":"Takeshita J, Eriksen WT, Raziano VT, et al. Racial differences in perceptions of psoriasis therapies: implications for racial disparities in psoriasis treatment. J Investig Dermatol. 2019;139:16729-e1.","journal-title":"J Investig Dermatol"},{"key":"1496_CR61","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1136\/bmj.325.7370.925","volume":"325","author":"SR Weingarten","year":"2002","unstructured":"Weingarten SR, Henning JM, Badamgarav E, et al. Interventions used in disease management programmes for patients with chronic illness-which ones work? Meta-analysis of published reports. BMJ. 2002;325:925.","journal-title":"BMJ"},{"key":"1496_CR62","doi-asserted-by":"publisher","first-page":"745","DOI":"10.2147\/CCID.S357743","volume":"15","author":"KH Shango","year":"2022","unstructured":"Shango KH, Abdole FA, Gonzalez SM, Farshchian M, Moossavi M. Medical student confidence in diagnosis of dermatologic diseases in skin of color. Clin Cosmet Investig Dermatol. 2022;15:745\u201350.","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"1496_CR63","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1377\/hlthaff.2019.01394","volume":"39","author":"TC Buchmueller","year":"2020","unstructured":"Buchmueller TC, Levy HG. The ACA\u2019s impact on racial and ethnic disparities in health insurance coverage and access to care. Health Aff (Millwood). 2020;39:395\u2013402.","journal-title":"Health Aff (Millwood)"},{"key":"1496_CR64","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1377\/hlthaff.2017.0293","volume":"36","author":"BD Sommers","year":"2017","unstructured":"Sommers BD, Maylone B, Blendon RJ, Orav EJ, Epstein AM. Three-year impacts of the Affordable Care Act: improved medical care and health among low-income adults. Health Aff (Millwood). 2017;36:1119\u201328.","journal-title":"Health Aff (Millwood)"},{"key":"1496_CR65","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1023\/A:1025148302636","volume":"22","author":"B Gray","year":"1997","unstructured":"Gray B, Stoddard JJ. Patient-physician pairing: does racial and ethnic congruity influence selection of a regular physician? J Community Health. 1997;22:247\u201359.","journal-title":"J Community Health"},{"key":"1496_CR66","doi-asserted-by":"publisher","first-page":"2552","DOI":"10.1007\/s40615-022-01435-y","volume":"10","author":"C Moore","year":"2023","unstructured":"Moore C, Coates E, Watson A, de Heer R, McLeod A, Prudhomme A. \u201cIt\u2019s important to work with people that look like me\u201d: Black patients\u2019 preferences for patient-provider race concordance. J Racial Ethn Health Disparities. 2023;10:2552\u201364.","journal-title":"J Racial Ethn Health Disparities"}],"container-title":["Dermatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-025-01496-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13555-025-01496-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-025-01496-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T13:15:48Z","timestamp":1758719748000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13555-025-01496-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,25]]},"references-count":66,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["1496"],"URL":"https:\/\/doi.org\/10.1007\/s13555-025-01496-x","relation":{},"ISSN":["2193-8210","2190-9172"],"issn-type":[{"value":"2193-8210","type":"print"},{"value":"2190-9172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,25]]},"assertion":[{"value":"9 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Nicole A. Negbenebor is a member of the Skin of Color Society speaker bureau and has served on an advisory board for UCB. Julia M. Riley has served on an advisory board for Novartis Pharmaceuticals Corporation and has served as an investigator for AbbVie Pharmaceuticals and Incyte Corporation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}